PDM
ROIV icon

Penn Davis McFarland’s Roivant Sciences ROIV Stock Holding History

Penn Davis McFarland’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55.9M Sell
1,580,191
-12,432
-0.8% -$367K 4.98% 4
2026
Q1 		$44.1M Sell
1,592,623
-265,666
-14% -$6.82M 4.32% 7
2025
Q4 		$40.3M Sell
1,858,289
-3,799
-0.2% -$75K 3.86% 7
2025
Q3 		$28.2M Buy
1,862,088
+170,456
+10% +$2.11M 2.91% 12
2025
Q2 		$19.1M Sell
1,691,632
-15,600
-0.9% -$169K 2.15% 17
2025
Q1 		$17.2M Buy
1,707,232
+58,206
+4% +$629K 2.04% 18
2024
Q4 		$19.5M Buy
1,649,026
+16,832
+1% +$199K 2.12% 20
2024
Q3 		$18.8M Buy
1,632,194
+275
+0% +$3.13K 2.12% 19
2024
Q2 		$17.2M Sell
1,631,919
-8,206
-0.5% -$89.9K 2.67% 19
2024
Q1 		$17.3M Buy
+1,640,125
New +$17.7M 2.68% 21

Other funds holding ROIV

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CA
Cache Advisors San Francisco, California $1.18B AUM 44.04% 1-Year Est. Return
SEIA
Signature Estate & Investment Advisors Los Angeles, California $5.56B AUM 26.66% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
EWM
Edge Wealth Management New York $594M AUM 24.92% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
LWA
Ledgewood Wealth Advisors Exeter, New Hampshire $188M AUM 18.45% 1-Year Est. Return

Penn Davis McFarland's ROIV Position: Q2 2026 in Review

Penn Davis McFarland reduced its Roivant Sciences (ROIV) stake by 0.78% in Q2 2026, selling an estimated $367K and leaving 1,580,191 shares worth $55.9M. The position accounts for 4.98% of the portfolio, ranked #4.

Penn Davis McFarland first reported a position in ROIV in Q1 2024 and has held it in 10 quarters since. 44 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Penn Davis McFarland held 1,580,191 shares of Roivant Sciences worth $55.9M as of Q2 2026.
  • Penn Davis McFarland sold 12,432 Roivant Sciences shares in Q2 2026, an estimated $367K.
  • Roivant Sciences made up 4.98% of Penn Davis McFarland's portfolio in Q2 2026, its #4 holding.
  • Penn Davis McFarland first reported a position in Roivant Sciences in Q1 2024 and has held it in 10 quarters since.
  • 44 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Penn Davis McFarland's 13F filing for Q2 2026, filed 15 Jul 2026.